Acadia: Q4 Earnings Snapshot
By AP News
Published - Feb 27, 2023, 04:33 PM ET
Last Updated - Jun 22, 2023, 07:18 PM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Monday reported a loss of $41.7 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 26 cents.
The results did not meet Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.
The drugmaker posted revenue of $136.5 million in the period, topping Street forecasts. Nine analysts surveyed by Zacks expected $134.4 million.
